Molecular Diagnostics Point of Care Market to be Valued at USD 4.84 Billion by 2027 | Industry Trend – High demand for point-of-care diagnostics

The Global Molecular Diagnostics Point of Care Market is projected to reach USD 4.84 billion in 2027. The main factors that are expected to strengthen high growth potential for POC MDx products are continuing research and development to miniaturize tests with molecular diagnostics that enable increased patient testing with higher precision and lower turnaround times.

Increasing demand in non-laboratory environments like pharmacy clinics, doctors, and home care tests, which are, by definition, portable and safe, would likely lead to lower demand on the market over the forecast period. The demand is expected to increase in CLIA tests. A number of large international bodies, including governments of developing countries, actively support and finance continuous research and development.

In addition, a wide variety of point-of-care testing technologies has been evolving rapidly over the previous decade with a view to extending its potential market to a wider range of Medical Faculties, initially focused on the screening, monitoring, and diagnosis of infectious diseases in low income developing countries. Therefore, cardiological monitoring, oncological testing, and hematological testing are now available and/or under development.

Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report@ https://www.emergenresearch.com/request-sample-form/11

Top Companies in Prefilled Syringes Market are:

BioMerieux, Abbott Laboratories, Roche Diagnostics, Bio-Rad Laboratories, Bayer Healthcare, Nipro Diagnostics, Danaher Corporation, Abaxis Inc., Dako, and OraSure Technologies Inc., among others.

Prefilled Syringes Market Drivers During Forecast Period:

By Test Location Outlook Segment:

Point-of-care Molecular Diagnostics products are used in majority places for the screening of infectious diseases as they offer the physicians a way to improve the quality of care by providing quick diagnosis and treatment approaches.

Test Location Outlook (Volume, Million Tons; Revenue, USD Billion; 2017-2027)

  • PoC
  • Over-the-Counter (OTC)

By Technology Outlook Segment:

PCR-based POC studies is a major contributor to the revenue of the overall market. This can be attributed to the widespread use of PCR-based technology for PCR products in molecular diagnosis. Commercialization of POC tests that deliver rapid real-time PCR analysis with high precision is expected to contribute to the market growth substantially.

ORDER NOW (Customized Report Delivered as per Your Specific Requirement)@ https://www.emergenresearch.com/select-license/11

Technology Outlook (Volume, Million Tons; Revenue, USD Billion; 2017-2027)

  • Hybridization-based
  • PCR-based
  • Microarray-based
  • Genetic Sequencing-based

Application Outlook (Volume, Million Tons; Revenue, USD Billion; 2017-2027)

  • Prenatal Testing
  • Infectious Diseases
  • Endocrinology
  • Hematology
  • Oncology
  • Others

End-Use Outlook (Volume, Million Tons; Revenue, USD Billion; 2017-2027)

  • Homecare
  • Decentralized Labs
  • Assisted Living Healthcare Facilities
  • Hospitals
  • Others

By Regional Outlook Segment:

  1. North America accounted for a considerable share of the industry and is expected to show lucrative growth over the forecast years due to the ever-growing incidences of infectious diseases, increasing approvals for CLIA products, and favorable policy implementations.
  2. Europe is projected to follow North America and the growth of the region can be accredited to the rising demand for rapid diagnosis and the development of novel molecular diagnostic tests for DNA analysis. The Asia Pacific is predicted to be the fastest-growing region in the projected period owing to the increasing population requiring clinical testing and availability of cost-effective PoC molecular tests.  

To identify the key trends in the industry and read full summary click on the link:   https://www.emergenresearch.com/industry-report/molecular-diagnostics-point-of-care-market

Regional Outlook (Volume, Million Tons; Revenue, USD Billion; 2017-2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • Rest of MEA

Reasons to buy the report:

  1. This study segments the Molecular Diagnostics Point of Care market and derives the precise valuation of the overall, as well as segment-based, market across different industry verticals, geographies, and products.
  2. The report will help participants understand the trajectory of the progress of the market and provide information on key drivers, restraints, challenges, threats, and opportunities for the growth of the Molecular Diagnostics Point of Care sectors.
  3. This Molecular Diagnostics Point of Care report would allow readers to be well-versed with the existing competition and gain more insights to improve their standing in the worldwide business. The competitive landscape considers the dominant competitors, along with product launches and technological advancements, strategic expansions, mergers and acquisitions, and procurement strategies implemented by key players in the Molecular Diagnostics Point of Care market.

Key features of the report:

  • To study the key aspects impacting the Molecular Diagnostics Point of Care market size.
  • To identify growth prospects in the Molecular Diagnostics Point of Care market.
  • To analyze the Molecular Diagnostics Point of Care market segments and deduce the dominant trends observed in the industry.
  • To examine the Molecular Diagnostics Point of Care market by investigating the available products, market share, and value proposition of the products.
  • To analyze the industry by assessing the scope and application of the Molecular Diagnostics Point of Care market and highlight the growth of each application.

Table of Content

Chapter 1. Methodology & Sources

    1.1. Market Definition

    1.2. Research Scope 

    1.3. Methodology

    1.4. Research Sources

          1.4.1. Primary

          1.4.2. Secondary

          1.4.3. Paid Sources

    1.5. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2020-2030

Chapter 3. Key Insights

Chapter 4. Molecular Diagnostics Point of Care Market Segmentation & Impact Analysis

    4.1. Molecular Diagnostics Point of Care Market Material Segmentation Analysis

    4.2. Industrial Outlook

          4.2.1. Market indicators analysis

          4.2.2. Market drivers’ analysis

          4.2.3. Market restraints analysis

    4.3. Technological Insights

    4.4. Regulatory Framework

    4.5. Porter’s Five Forces Analysis

    4.6. Competitive Metric Space Analysis

    4.7. Price trend Analysis

    4.8. Covid-19 Impact Analysis

Continued…

Explore Complete Table of Content@ https://www.emergenresearch.com/industry-report/molecular-diagnostics-point-of-care-market

Insights into our Other Published Healthcare Reports:

Pharmacovigilance Market Size Worth USD 12.48 Billion by 2027 | CAGR of 12.5%

Radiation Dose Management Market to Reach USD 505.3 Million By 2027 | CAGR of 12.6%

Cell Culture Market Size Worth USD 45.12 Billion By 2027 | CAGR of 10.3%

Gene Editing Market Size Worth USD 15.79 Billion By 2027 | CAGR of 17.2%

Joint Reconstruction Devices Market Size Worth USD 36.81 Billion By 2027 | CAGR of 6.3%

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Read Full Press Release@ https://www.emergenresearch.com/press-release/global-molecular-diagnostics-point-of-care-market

Back to news